CClinicalTrials.gg
CompletedNCT02013921APQUpdated Jan 11, 2019

Interest of Daily Physical Activity After Cancer Treatment

An observational study in Cancer and Tiredness, sponsored by University Hospital, Limoges. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-01-11.

Sponsored by University Hospital, Limoges · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
31
Ages
18 Years and older
Sex
All
01

Study summary

Many studies have demonstrated the beneficial effects of Adapted Physical Activity (APA) in different cancer types.

It therefore seems necessary to assess spontaneous Physical Activity in order to integrate it to the overall calculation of physical activity in clinical practice.

To assess the AP, two types of methods are validated : the subjective method using a questionnaries and objective method using a pedometer , accelerometer or measures calorimetry .

Subjective method shows , good acceptability by patients and low cost but can sometimes lead to poor estimation of the level of activity.

Objective methods obviously increase the accuracy of assessments but are more difficult to use for epidemiological studies , less accepted by the patient and more expensive.

In this study the investigators will measure the spontaneous Daily Physical Activity by both methods andd evaluate the correclation.

02

Conditions studied

  • Cancer
  • Tiredness

Browse trials for

Keywords

  • Physical activity
  • Cancer
03

In context

Fatigue

1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.

This study's enrollment of 31 is below the median of 100 across 367 observational studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

University Hospital, Limoges is the lead sponsor of 255 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with a breast cancer and are completing treatment

Inclusion criteria

  • adult (age ≥ 18 years)
  • Having been informed of the study orally and in writing and have not expressed opposition to his participation
  • Performance status \<2
  • Invasive breast adenocarcinoma, histologically documented.
  • Patients with a breast cancer and are completing treatment

Exclusion criteria

  • Patient with metastatic cancer.
  • Patient for which monitoring required by the protocol is impossible.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
31 participants (actual)
Patient registry
No

Groups and cohorts

  • Physical Activity

    Patients with a breast cancer and are completing treatment

    Other: Physical activity

Interventions

  • OtherPhysical activity
06

What researchers measure

Primary outcomes

  1. Daily physical activity assessment at 3 months

    Physical activity is measured by means of an Actigraph. Patients will measure their daily physical activity , three times during one week espaced by 1 month.

    Time frame: Month 3

07

Study locations

1 site
  • Oncologie- CHU Limoges
    Limoges, 87000, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 11, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02013921
Lead sponsor
University Hospital, Limoges
Responsible party
Sponsor
First posted
Dec 17, 2013
Start date
Dec 2013
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Jan 11, 2019

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion